BlackRock’s Kestra Medical Technologies KMTS Stock Holding History
Bought
Maintained
Sold
Other funds holding KMTS
BCI
AP
YF
EAM
VCM
BlackRock's KMTS Position: Q1 2026 in Review
BlackRock increased its Kestra Medical Technologies (KMTS) stake by 37% in Q1 2026, buying an estimated $10.7M and bringing the position to 1,689,247 shares worth $33.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2761.
BlackRock first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.
- BlackRock held 1,689,247 shares of Kestra Medical Technologies worth $33.7M as of Q1 2026.
- BlackRock bought 454,561 Kestra Medical Technologies shares in Q1 2026, an estimated $10.7M.
- Kestra Medical Technologies made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2761 holding.
- BlackRock first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
- 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.